ISSN:
1476-5535
Keywords:
Epidermal growth factor
;
Exotoxin
;
Cancer
Source:
Springer Online Journal Archives 1860-2000
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
Summary Transforming growth factor-alpha (TGFα)-pseudomonas exotoxin-40 (PE40) is a chimeric protein consisting of an N-terminal TGFα domain fused to a C-terminal 40-kDa segment of the pseudomonas exotoxin A protein. TGFα-PE40 exhibits the receptor binding activity of TGFα and the cell killing activity of PE40. In the current study, we report that a modified TGFα-PE40 derivative significantly prolongs the survival of nude mice bearing tumors derived from cell lines which express the epidermal growth factor receptor (EGFR). In addition, the therapeutic benefit of this protein is mediated by specific binding to the EGF receptor. These results indicate that a therapeutic window exists in vivo for the use of some growth factor-toxin fusion proteins as anticancer agents.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF01575884
Permalink